PEN
Penumbra, Inc.
226.68
USD
This page is just a preview of the data found in TrendSpider’s full version
Penumbra, Inc. stock is up 18.59% since 30 days ago. The next earnings date is Feb 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 8 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 4 PUTs, 6 CALLs. 50% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 14 Nov 16:56 | 20 Dec, 2024 | 140.00 | 341 | ||
| 14 Nov 17:29 | 15 Dec, 2023 | 240.00 | 320 | ||
| 15 Nov 19:32 | 15 Dec, 2023 | 230.00 | 222 | ||
| 16 Nov 15:44 | 15 Dec, 2023 | 230.00 | 231 | ||
| 16 Nov 15:47 | 15 Dec, 2023 | 230.00 | 231 | ||
| 17 Nov 18:44 | 15 Dec, 2023 | 190.00 | 206 | ||
| 27 Nov 20:56 | 15 Dec, 2023 | 220.00 | 84 | ||
| 29 Nov 14:53 | 19 Jan, 2024 | 230.00 | 87 | ||
| 29 Nov 15:40 | 20 Dec, 2024 | 290.00 | 34 | ||
| 29 Nov 16:14 | 20 Dec, 2024 | 270.00 | 50 |
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand.
